Nikakis Jacqueline, Malkov Denis, Tale Ermin, Mangla Mahima, Keys Jordan, Li To Shan, Yao Sheldon, Cohen Todd J
Department of Clinical Specialties, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.
Department of Medicine, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA.
J Innov Card Rhythm Manag. 2024 Dec 15;15(12):6107-6112. doi: 10.19102/icrm.2024.15121. eCollection 2024 Dec.
This double-blind randomized controlled trial investigated the effects of osteopathic manipulative treatment (OMT) on cardiac arrhythmias in patients with cardiac implantable electronic devices (CIEDs). Participants (n = 41) with CIEDs were randomly assigned to either the OMT group or the control group (light touch/sham) and received a one-time intervention. No significant change in arrhythmia burden was found in the 1 month following intervention ( = .14). Discrete heart rate (HR), HR variability (HRV), and activity data were obtained from CIEDs in 17 of 41 subjects 1, 3, 7, 14, and 30 days prior to and after intervention. No significant difference was observed. An additional short-term substudy was performed on 20 subjects at the time of the intervention (5 min prior to and after intervention), and HR, respiratory rate, blood pressure, blood oxygen saturation (SpO), and 1-min short-term HRV were compared. This study did not demonstrate an effect of OMT on arrhythmias, HR, respiratory rate, blood pressure, and blood SpO. However, differences in OMT versus sham were observed for short-term HRV ( = .022) and a trend for long-term HRV. Importantly, there were no reported adverse effects with either intervention. OMT appears to be safe in cardiac patients.
这项双盲随机对照试验研究了整骨手法治疗(OMT)对心脏植入式电子设备(CIED)患者心律失常的影响。41名CIED患者被随机分为OMT组或对照组(轻触/假治疗),并接受一次性干预。干预后1个月心律失常负担无显著变化(P = 0.14)。在41名受试者中的17名中,于干预前后1、3、7、14和30天从CIED获取离散心率(HR)、心率变异性(HRV)和活动数据。未观察到显著差异。在干预时(干预前后5分钟)对20名受试者进行了一项额外的短期子研究,并比较了HR、呼吸频率、血压、血氧饱和度(SpO)和1分钟短期HRV。本研究未证明OMT对心律失常、HR、呼吸频率、血压和血液SpO有影响。然而,观察到OMT与假治疗在短期HRV方面存在差异(P = 0.022)以及长期HRV有变化趋势。重要的是,两种干预均未报告有不良反应。OMT在心脏病患者中似乎是安全的。